DE69425581T2 - Methode zur stabilisierung von protein c oder aktiviertem protein c und stabilisierte verbindungen - Google Patents

Methode zur stabilisierung von protein c oder aktiviertem protein c und stabilisierte verbindungen

Info

Publication number
DE69425581T2
DE69425581T2 DE69425581T DE69425581T DE69425581T2 DE 69425581 T2 DE69425581 T2 DE 69425581T2 DE 69425581 T DE69425581 T DE 69425581T DE 69425581 T DE69425581 T DE 69425581T DE 69425581 T2 DE69425581 T2 DE 69425581T2
Authority
DE
Germany
Prior art keywords
protein
stabilizing
activated protein
activated
stabilized compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69425581T
Other languages
English (en)
Other versions
DE69425581D1 (de
Inventor
Kazumasa Miyata
Yoshinori Akimoto
Yoichi Ogata
Tomohiro Nakagaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Ltd
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken, Teijin Ltd filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Publication of DE69425581D1 publication Critical patent/DE69425581D1/de
Application granted granted Critical
Publication of DE69425581T2 publication Critical patent/DE69425581T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69425581T 1993-10-29 1994-10-27 Methode zur stabilisierung von protein c oder aktiviertem protein c und stabilisierte verbindungen Expired - Lifetime DE69425581T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5292500A JP2886061B2 (ja) 1993-10-29 1993-10-29 プロテインｃもしくは活性化プロテインｃの安定化方法及び安定化組成物
PCT/JP1994/001804 WO1995011698A1 (fr) 1993-10-29 1994-10-27 PROCEDE DE STABILISATION DE PROTéINE C ACTIVEE OU NON ACTIVEE ET COMPOSITION STABILISEE

Publications (2)

Publication Number Publication Date
DE69425581D1 DE69425581D1 (de) 2000-09-21
DE69425581T2 true DE69425581T2 (de) 2001-01-11

Family

ID=17782629

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425581T Expired - Lifetime DE69425581T2 (de) 1993-10-29 1994-10-27 Methode zur stabilisierung von protein c oder aktiviertem protein c und stabilisierte verbindungen

Country Status (9)

Country Link
US (1) US5962299A (de)
EP (1) EP0726076B1 (de)
JP (1) JP2886061B2 (de)
KR (1) KR100296395B1 (de)
CN (1) CN1210061C (de)
AT (1) ATE195425T1 (de)
AU (1) AU679581B2 (de)
DE (1) DE69425581T2 (de)
WO (1) WO1995011698A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL335802A1 (en) * 1997-03-24 2000-05-22 Lilly Co Eli Method of treating vascular disorders
EP1561469A1 (de) * 1997-04-28 2005-08-10 Eli Lilly & Company Aktiviertes Protein C Formulierungen
BR9809304B1 (pt) * 1997-04-28 2011-02-08 formulação liofilizada estável, processo para preparação da mesma, bem como forma de dosagem unitária.
AU769144B2 (en) * 1997-04-28 2004-01-15 Eli Lilly And Company Improved methods for processing activated protein C
US6630137B1 (en) * 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
EP1557463A1 (de) * 1997-04-28 2005-07-27 Eli Lilly & Company Verbesserte Methoden zur Verarbeitung von aktiviertem Protein C
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
JP2004511428A (ja) 2000-05-24 2004-04-15 イーライ・リリー・アンド・カンパニー 凝固亢進状態を処置するための製剤および方法
JP2005528351A (ja) * 2002-03-08 2005-09-22 イーライ・リリー・アンド・カンパニー 活性化プロテインｃ製剤
DE10333317A1 (de) * 2003-07-22 2005-02-17 Biotecon Therapeutics Gmbh Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
CN103893135B (zh) * 2014-03-28 2017-01-11 中国医学科学院输血研究所 一种人血浆蛋白c的冻干稳定剂组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2601959B2 (ja) * 1990-10-15 1997-04-23 富士写真フイルム株式会社 シート搬送区分装置
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
JP3043558B2 (ja) * 1993-10-29 2000-05-22 財団法人化学及血清療法研究所 ヒト活性化プロテインｃ調製物及びその製法
JPH07165605A (ja) * 1993-12-16 1995-06-27 Teijin Ltd 活性化プロテインｃバイアル

Also Published As

Publication number Publication date
DE69425581D1 (de) 2000-09-21
AU8003094A (en) 1995-05-22
US5962299A (en) 1999-10-05
KR100296395B1 (ko) 2001-10-24
EP0726076A4 (de) 1997-10-29
KR960705580A (ko) 1996-11-08
JPH07126184A (ja) 1995-05-16
WO1995011698A1 (fr) 1995-05-04
CN1138297A (zh) 1996-12-18
ATE195425T1 (de) 2000-09-15
AU679581B2 (en) 1997-07-03
EP0726076A1 (de) 1996-08-14
EP0726076B1 (de) 2000-08-16
JP2886061B2 (ja) 1999-04-26
CN1210061C (zh) 2005-07-13

Similar Documents

Publication Publication Date Title
AU783155B2 (en) Stabilized protein preparation and process for its preparation
DE69425581D1 (de) Methode zur stabilisierung von protein c oder aktiviertem protein c und stabilisierte verbindungen
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
KR100261360B1 (ko) 바이러스-유리된 트롬빈 농축물 제조방법
EP0292003B1 (de) Stabilisierung von biologischen und pharmazeutischen Produkten während der Inaktivierung von viralen und bakteriellen Keimen
NO2006006I1 (no) Aktivert protein C
ES2080060T3 (es) Proteinas que tienen actividad de union a interferon-gamma.
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
DK0512087T3 (da) Fremgangsmåde til reaktivering af denaturerede proteiner
RU95107705A (ru) Полипептид, рекомбинантный полинуклеотид, вакцина, применение вакцины
CA2175202A1 (en) A method for stabilizing protein c or activated protein c and the stabilized composition obtained by said method
DE3825118A1 (de) Expression der viral kodierten protease p2a des hrv2